Parkinson’s disease is diagnosed primarily through a neurological exam, not a single definitive test. There is no blood test or brain scan that confirms it on its own. Instead, a neurologist evaluates your movement, reviews your symptoms, and uses imaging and medication trials to build a case. The process often takes time, and early diagnostic accuracy sits around only 58%, improving significantly as the disease progresses and its pattern becomes clearer.
What Doctors Look for First
The foundation of a Parkinson’s diagnosis is the presence of motor parkinsonism: slowed movement (called bradykinesia) combined with either a resting tremor or muscle rigidity. Both elements need to be present. Bradykinesia on its own isn’t enough, and neither is tremor alone. This definition comes from the Movement Disorder Society’s diagnostic criteria, which neurologists worldwide rely on.
Once parkinsonism is confirmed, the neurologist then determines whether Parkinson’s disease specifically is causing it, since several other conditions can produce similar motor symptoms. This involves checking for red flags that suggest a different diagnosis and looking for supportive features that increase confidence the diagnosis is correct.
The Neurological Exam
The physical exam is hands-on and surprisingly low-tech. It begins before you even realize you’re being tested. While you’re sitting in the chair, the neurologist is already watching your body for spontaneous movements, how often you blink, whether your hands tremor at rest, and whether you fidget or shift position. Reduced blinking and a still, mask-like facial expression are early signs.
To test for bradykinesia, you’ll be asked to perform repetitive movements: tapping your thumb and forefinger together, opening and closing your fist, or flipping your hand palm-up and palm-down as fast and as large as you can, for at least ten repetitions. The neurologist is watching not just for slowness but for the movements getting progressively smaller or more irregular, which is distinctive to Parkinson’s.
You’ll also be asked to stand up from a chair with your arms crossed over your chest, testing whether your legs and trunk can generate enough coordinated power without your arms helping. During a walking assessment, the doctor observes your stride length, whether your arms swing naturally, and how your heels strike the ground. Reduced arm swing on one side is a classic early finding.
The pull test checks your balance. The examiner stands behind you and gives a firm tug on your shoulders. If you need more than two steps backward to catch yourself, or you can’t stabilize at all, it suggests impaired postural reflexes. A finger-to-nose test evaluates coordination by having you alternate between touching the examiner’s finger and your own nose.
The Role of Brain Imaging
A standard MRI of the brain typically looks normal in early Parkinson’s disease, and that’s actually the point. The MRI isn’t ordered to find Parkinson’s. It’s ordered to rule out other conditions that can mimic it: small strokes in the deep brain structures, a buildup of fluid in the brain (normal pressure hydrocephalus), tumors, or damage from toxic exposures like manganese or carbon monoxide. Each of these has characteristic patterns on MRI that a radiologist can identify. If the MRI is clean, it removes these alternatives from the list.
A more specialized scan called a DaTscan is sometimes used when the diagnosis is uncertain. This imaging technique uses a radioactive tracer that binds to dopamine transporters in the brain, allowing doctors to see whether dopamine-producing cells are degenerating. In Parkinson’s, these transporters are visibly depleted. The scan is particularly useful for distinguishing Parkinson’s from essential tremor or medication-induced tremor, neither of which involves dopamine cell loss. A DaTscan can confirm that dopamine degeneration is happening, but it can’t distinguish Parkinson’s from a few other rarer conditions that also destroy dopamine cells.
The Medication Trial
One of the most telling diagnostic tools is also a treatment: levodopa, the primary medication used in Parkinson’s. If your motor symptoms improve meaningfully after taking it, that response itself counts as supportive evidence for the diagnosis. Research has identified a 33% improvement in motor scores as the optimal cutoff for a positive result, though this threshold catches about 70% of true Parkinson’s cases while correctly excluding about 71% of non-Parkinson’s cases. It’s a useful signal, not a perfect one.
Some people with early or mild Parkinson’s don’t show a dramatic levodopa response right away, so a negative result doesn’t automatically rule it out. Conversely, a few other conditions can also partially respond to the medication. This is why the medication trial is treated as one piece of evidence among many rather than a standalone test.
Why Misdiagnosis Is Common Early On
Parkinson’s is notoriously difficult to diagnose in its earliest stages. Autopsy studies, which provide the only definitive confirmation, have found that among patients given an initial early diagnosis of Parkinson’s, only about 58% actually had the disease. Roughly 40% of people clinically diagnosed with early Parkinson’s turn out to have something else.
The conditions most commonly confused with Parkinson’s include multiple system atrophy and progressive supranuclear palsy, both of which can look nearly identical in their first few years. Certain red flags help distinguish them. Severe drops in blood pressure upon standing, early urinary incontinence requiring a catheter, or unusual symptoms like involuntary facial movements, inspiratory sighing, hand and foot contractures, or uncontrollable laughing and crying all raise suspicion for multiple system atrophy. Notably, none of these red flag features appeared in confirmed Parkinson’s patients within three years of symptom onset in one large study, making their early presence a meaningful warning sign.
This is why neurologists trained specifically in movement disorders are so important for accurate diagnosis. Your family doctor or a general neurologist may start the process, but complex or uncertain cases benefit from a specialist who sees these conditions regularly and can pick up on subtle distinguishing features.
The Typical Path to Diagnosis
Most people first bring their symptoms to a primary care doctor, who then refers them to a neurologist. The neurologist performs the motor exam, orders imaging to exclude other causes, and may start a medication trial. In straightforward cases where the symptoms are clearly one-sided, include a classic resting tremor, and respond well to medication, a confident diagnosis can sometimes be made in one or two visits.
More often, it takes time. Neurologists frequently recommend regular follow-up appointments over months or even years to watch how symptoms evolve. Parkinson’s has a characteristic progression: it starts on one side of the body and gradually involves the other, non-motor symptoms like sleep disturbances and loss of smell often precede or accompany the motor symptoms, and the response to levodopa typically remains strong for years. Watching this pattern unfold is itself a diagnostic tool. A condition that behaves differently over time may prompt the neurologist to reconsider.
Newer Testing Options
A skin biopsy test has emerged as a promising addition to the diagnostic toolkit. Parkinson’s disease involves the abnormal accumulation of a protein called alpha-synuclein, and this protein deposits not only in the brain but also in nerve fibers throughout the body, including the skin. A study published in JAMA found that skin biopsies detected this abnormal protein in 92.7% of Parkinson’s patients while correctly identifying 96.7% of healthy controls as negative.
This test is already commercially available in some settings, though it hasn’t yet become a routine part of every diagnostic workup. Blood-based biomarker tests are also under active development, but none have reached the reliability needed for standard clinical use. Current blood tests lack the sensitivity and specificity to diagnose Parkinson’s on their own, though combining multiple biomarker types with imaging may eventually change that.
For now, diagnosing Parkinson’s remains a clinical skill: a neurologist synthesizing what they observe in the exam room, what imaging rules out, how your body responds to medication, and how your symptoms change over time. It’s an imperfect process, but one that improves substantially with specialist expertise and follow-up.